Second serosurveillance study in The Netherlands for the evaluation of the Dutch National Immunisation Programme: the PIENTER 2 study

ISRCTN ISRCTN20164309
DOI https://doi.org/10.1186/ISRCTN20164309
Secondary identifying numbers N/A
Submission date
27/06/2007
Registration date
27/06/2007
Last edited
18/03/2013
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Infections and Infestations
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Study website

Contact information

Dr F.R.M. van der Klis
Scientific

National Institute of Public Health and Environmental Protection (RIVM)
afdeling LIS
P.O. Box 1
Bilthoven
3720 BA
Netherlands

Phone +31 (0)30 274 2272
Email fiona.van.der.klis@rivm.nl

Study information

Study designObservational, cross-section survey
Primary study designObservational
Secondary study designCross-section survey
Study setting(s)Not specified
Study typeScreening
Scientific title
Study acronymPIENTER 2
Study objectivesThe age-specific seroprevalence of a cross-section of the Dutch population for the vaccinations used in the Dutch National Immunisation Programme.
Ethics approval(s)Approval received from the local ethics committee (Stichting Therapeutische Evaluatie
Geneesmiddelen [STEG]) on the 11th October 2005 (ref: R05-044).
Health condition(s) or problem(s) studiedVaccination and the National Immunisation Program, infectious diseases
InterventionA blood sample and a questionnaire regarding health perception, diseases (including sexually transmitted), vaccination data.
Intervention typeOther
Primary outcome measureThe age-specific seroprevalence (immunity) for diseases included in the National Immunisation Program of the Dutch general population.

As each participant is sampled only once, there will be only one timepoint measurement per person. The timepoint for the complete study population varies from February 2006 to June 2007. Because the participants represent a cross section of the Dutch population aged 0 to 80, we will be able to estimate the seroprevalence in the Dutch population in 2006-2007.
Secondary outcome measures1. The age-specific seroprevalence against other infectious diseases, in particular those that might be vaccine preventable in the near future and against those diseases with a frequent subclinical course
2. The age-specific seroprevalence amongst the allochtonous populations (additional sample)
3. The age-specific seroprevalence amongst non-vaccinated orthodox reformed individuals (additional sample)

As each participant is sampled only once, there will be only one timepoint measurement per person. The timepoint for the complete study population varies from February 2006 to June 2007. Because the participants represent a cross section of the Dutch population aged 0 to 80, we will be able to estimate the seroprevalence in the Dutch population in 2006-2007.
Overall study start date06/02/2006
Completion date19/06/2007

Eligibility

Participant type(s)Patient
Age groupAdult
SexNot Specified
Target number of participants7700
Key inclusion criteria1. Subject is part of the study sample
2. Aged 0 - 79 years old
3. Has received a personal invitation for the study
4. Subject has given written informed consent before start of the study
Key exclusion criteriaSubject is an employee of the National Institute of Public Health and Environmental Protection (RIVM).
Date of first enrolment06/02/2006
Date of final enrolment19/06/2007

Locations

Countries of recruitment

  • Netherlands

Study participating centre

National Institute of Public Health and Environmental Protection (RIVM)
Bilthoven
3720 BA
Netherlands

Sponsor information

National Institute of Public Health and Environmental Protection (RIVM) (The Netherlands)
Government

P.O. Box 1
Bilthoven
3720 BA
Netherlands

Phone +31 (0)30 274 9111
Email info@rivm.nl
Website http://www.rivm.nl/en/
ROR logo "ROR" https://ror.org/01cesdt21

Funders

Funder type

Government

The Netherlands Ministry of Health, Welfare and Sport (The Netherlands)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 19/10/2012 Yes No
Results article results 01/04/2014 Yes No